ESTIMATING THE POTENTIAL BUDGET IMPACT OF ZELBORAF (VEMURAFENIB) FOR ADVANCED MELANOMA TREATMENT IN BRAZILIAN PRIVATE HEALTH CARE SYSTEM

被引：0
|
作者：
Tsuchiya, C. T. [1 ]
Buschinelli, C. T. [1 ]
Maximo, M. F. M. [1 ]
Tobaruella, F. S. [1 ]
Borges, L. G. [1 ]
机构：
[1] Roche Brazil, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.641
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A132 / A132
页数：1
相关论文
共 50 条
  • [11] Budget Sequester: Potential Impact on Health Care Providers
    Ferrara, M. J.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2014, 35 (04) : 657 - 659
  • [12] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF VISCOSUPPLEMENTATION WITH ORTHOVISC™ (HYALURONAN) IN KNEE OSTEOARTHRITIS, FROM THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM PERSPECTIVE
    Rezende, M. U.
    Hernandez, A. J.
    Namba, M. M.
    Fernandes, R. A.
    Takemoto, M. L. S.
    Santos, P. M. L.
    Repsold, D. M.
    Silva, R. C.
    Andrade, P. C.
    VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
  • [13] A FIVE YEARS BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF ADALIMUMAB FOR CROHN'S DISEASE PATIENTS FROM THE PERSPECTIVE OF THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Menezes, F. G.
    Chibana, V
    VALUE IN HEALTH, 2015, 18 (07) : A663 - A663
  • [14] THE COST OF STRONG OPIOID TREATMENT OF ONCOLOGICAL PAIN IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Paloni, E. D. M. P.
    Bonachela Alves, F.
    Morais, A. D.
    Pereira, M. L.
    Bahmdouni, L.
    VALUE IN HEALTH, 2011, 14 (07) : A444 - A444
  • [15] Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
    Nita, Marcelo Eidi
    Eliaschewitz, Freddy G.
    Ribeiro, Eliane
    Asano, Elio
    Barbosa, Elias
    Takemoto, Maira
    Donato, Bonnie
    Rached, Roberto
    Rahal, Elaine
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (03): : 294 - 301
  • [16] BUDGET IMPACT ANALYSIS OF CRIZOTINIB IN THE TREATMENT OF ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
    Alexandre, R. F.
    Squiassi, H. B.
    Santana, C. F.
    VALUE IN HEALTH, 2017, 20 (05) : A97 - A98
  • [17] THE COST OF A SCHIZOPHRENIA RELAPSE IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
    Bahmdouni, L. S. K.
    Pereira, M. L.
    Ferreira, C. N.
    Santana, C. F. S. D.
    Salles, G. R. D.
    VALUE IN HEALTH, 2012, 15 (04) : A87 - A87
  • [18] Vemurafenib Targeted Inhibition of Mutated BRAF for Treatment of Advanced Melanoma and Its Potential in Other Malignancies
    Sharma, Anant
    Shah, Sachin R.
    Illum, Henrik
    Dowell, Jonathan
    DRUGS, 2012, 72 (17) : 2207 - 2222
  • [19] BUDGET IMPACT ANALYSIS OF ZOLEDRONIC ACID IN POST MENOPAUSAL OSTEOPOROSIS BY BRAZILIAN PUBLIC HEALTH CARE SYSTEM
    Suzuki, C.
    Navarro, J.
    Pepe, C.
    VALUE IN HEALTH, 2009, 12 (07) : A522 - A522
  • [20] ESTIMATING THE BUDGET IMPACT OF ADDING OMALIZUMAB TO STANDARD THERAPY IN PATIENTS WITH UNCONTROLLED SEVERE ALLERGIC ASTHMA FROM PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
    Suzuki, C.
    Santoni, N. B.
    Silva, N. L.
    VALUE IN HEALTH, 2013, 16 (03) : A232 - A233
12345